Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.
Johnson & Johnson and its subsidiary Janssen Pharmaceuticals have agreed to settle Topamax birth defect lawsuits. Plaintiffs alleged that Topamax epilepsy drug side effects birth defects including cleft lips, cleft palates and other congenital malformations.
The Topamax global settlements were announced last week in Pennsylvania state court, stating that agreements have been reached in 76 complaints. According to a report, the drug manufacturers are exposed to face at least 60 additional cases that are centralized in Philadelphia.
DePuy Orthopaedics is exposed to several thousand DePuy Pinnacle hip lawsuits, which allege defective metal hip design and early failure of the implant. The first federal bellwether trials for the metal-on-metal hip replacement system are set to begin in September 2014, in the Northern District of Texas in Dallas.
After 33 grueling days of hotly contested trial testimony, the first federal Actos bladder cancer lawsuit trial has ended. The jury is scheduled to hear closing arguments on Monday and then deliberations will begin.
Good news for Transvaginal mesh and sling plaintiffs and it’s more bad news for Johnson and Johnson’s (J&J) Ethicon division in its ongoing vaginal mesh debacle. The company will have to pay out again, in these many cases to go to court over its allegedly defective transvaginal mesh products and urinary incontinence slings.
Johnson & Johnson, the world’s biggest maker of medical products, was ordered by a Texas jury to pay $1.2 million to a woman who alleged that vaginal-mesh implants to treat incontinence was defectively designed. This was the first verdict against the company over those devices.
General Motors (GM) Co., is exposed to a barrage of lawsuits in the U.S. and Canada over faulty ignition switches. According to sources, GM was served with the first wrongful-death suit involving two fatalities in a 2006 car crash. GM recalled 1.6 million vehicles in February.
Plaintiff Cobalt Death Claims
Megan Phillips, aged 17, was driving a 2005 Chevrolet Cobalt with two friends in Wisconsin when the ignition switch moved to the “accessory” position and cut power to the car. The Cobalt hit a telephone junction box and two trees and the air bags didn’t deploy. Phillips was seriously injured and her two passengers were killed.
More 30 AndroGel lawsuits filed in Northern District of Illinois federal court will be centralized before U.S. District Judge Matthew F. Kennelly. The testosterone injury lawsuits allege that men suffered heart attacks, strokes and blood clots that were caused by side effects of the testosterone treatment.
The Executive Committee in the Northern District of Illinois on March 14, ordered that the federal cases will be assigned to Judge Kennelly for consolidated pretrial proceedings. This pre-trial consolidation is typically seen in mass tort pharmaceutical litigation. This means that nationwide federal consolidation in a multidistrict ligation (MDL) cannot be far behind and more likely than not the nationwide testosterone cases will end up in Chicago, Illinois.
According to a New York Times investigation, the engineers at General Motors knew about a dangerous and faulty ignition switch back in 2009. At a meeting on May 15, 2009, they knew that data in the black boxes of Chevrolet Cobalts confirmed a potentially fatal defect existed in thousands of cars.
According to legal documents, G.M. told the families of accident victims and other customers that it did not have enough evidence of any defect in their cars. In February, G.M. recalled 1.6 million Cobalts and other models, saying that if the switch was bumped or weighed down it could shut off the engine’s power and disable air bags.
According to the U.S. federal court where the Stryker Rejuvenate hip lawsuits have been consolidated, the cases in the multidistrict litigation (MDL) will be ready for trial during the summer of 2015.
Stryker Rejuvenate cases, are heading to early trial dates, known as “bellwether” trials, which helps the parties determine how juries may respond to trial evidence and testimony.
AbbVie, the manufacturer of AndroGel, is exposed to another product liability lawsuit. Kimberly Dula, from Georgia claims that the company failed to warn about the heart risks from AndroGel. Dula claims that he suffered three heart attacks as a result of using the testosterone gel.
49 year old Dula filed the complaint recently in March, in the U.S. District Court for the Northern District of Illinois. There are now several Androgel lawsuits filed throughout the U.S., claiming that the drug manufacturer failed to warn about the risk of heart attacks, strokes, deep vein thrombosis, pulmonary embolism blood clots and wrongful death.
The first St. Jude Riata federal bellwether trial has been scheduled for February 2015. This trial involves two filed product liability lawsuits against St. Jude. U.S. District Judge James V. Selna is presiding over the St. Jude Riata lawsuits filed in the U.S. District Court for the Central District of California.